Hypoglycemia and resistance to ketoacidosis in a subject without functional insulin receptors

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 7, 2001, Pages 3319-3326

  Ogilvy Stuart, A L ^a,d   Soos, M A ^a,b   Hands, S J ^c   Anthony, M Y ^c   Dunger, D B ^a,b   O'Rahilly, S ^a,b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d Rosie Maternity Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; FATTY ACID; GROWTH HORMONE; INSULIN; INSULIN RECEPTOR; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C RECEPTOR;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HORMONAL REGULATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOINSULINEMIA; INSULIN BLOOD LEVEL; KETOACIDOSIS; KETOGENESIS; KNOCKOUT MOUSE; LEPRECHAUNISM; LIPID METABOLISM; MALE; MORTALITY; NEWBORN; PANCREAS ISLET; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL;

EID: 0034920467     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.7.7631     Document Type: Article

References (55)

1. Two mutant alleles of the insulin receptor in a patient with extreme insulin resistance
2. Mutagenesis of Lysine 460 in the human insulin receptor: Effects upon receptor recycling and cooperative interactions among binding sites
3. A mutation in the cysteine-rich domain of the insulin-receptor that impairs post-translational processing and transport or receptors to the plasma membrane
4. Homozygous deletion of the human insulin receptor gene results in leprechaunism
5. Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism
6. Leprechaunism and homozygous nonsense mutation in the insulin receptor gene
7. A mutation in the insulin receptor that impairs proreceptor processing but not insulin binding
8. Homozygosity for a null allele of the insulin receptor gene in a patient with leprechaunism
9. Severe resistance to insulin and insulin-like growth factor-I in cells from a patient with leprechaunism as a result of two mutations in the tyrosine kinase domain of the insulin receptor
10. Leprechaunism: A euphemism for a rare familial disorder
11. Leprechaunism
12. Dystrophic changes associated with leprechaunism in a male infant
13. Leprechaunism (Donohue syndrome)
14. Glucose kinetics in Leprechaunism: Accelerated fasting due to insulin resistance
15. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
16. Congenital absence of islets of Langerhans
17. Molecular scanning of the insulin receptor gene in syndromes of insulin resistance
18. Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action
19. The use of an automated microsampling system for the characterisation of growth hormone pulsatility in newborn babies
20. Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects: Evidence against a modulating role for insulin
21. Sensitive and specific two site immunoradiometric assays for human insulin, proinsulin, 65-66 and 32-33 split proinsulin
22. Micro-method for measurement of sub-nanomole amounts of triglycerol
23. Micro-method for preparing perchloric extracts of blood
24. The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics
25. Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluids
26. Purification and assay of insulin-like growth factor binding protein-1: Measurement of circulating levels throughout pregnancy
27. Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor
28. Expression and characterization of a functional human insulin-like growth factor I receptor
29. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity
30. The skipping of constitutive exons in vivo induced by nonsense mutations
31. Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monoclonal antibodies
32. A region of the insulin receptor important for ligand binding (residues 450-601) is recognized by patients' autoimmune antibodies and inhibitory monoclonal antibodies
33. A monoclonal anti-peptide antibody reacting with the insulin receptor β-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptor
34. Lilly lecture: Molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene
35. Molecular defects of the insulin receptor gene
36. The insulin receptor: Structure, function, and signaling
37. Mapping of an NH2-terminal ligand binding site of the insulin receptor by alanine scanning mutagenesis
38. Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin
39. The insulin-like growth factor-1 receptor. Structure, ligand binding mechanism and signal transduction
40. Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking
41. Characteristics of hepatic receptors for somatomedin C-/insulin-like growth factor I and insulin in the developing human
42. Growth hormone insensitivity syndrome (Laron syndrome): Main characteristics and effects of IGF1 treatment
43. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat: A combined in vivo and in vitro evaluation
44. Studies of acute effects of insulin-like growth factors I and II in human fat cells
45. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin
46. Acute and chronic regulation of serum sex hormone-binding globulin levels by plasma insulin concentrations in male noninsulin-dependent diabetes mellitus patients
47. The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver
48. Ineffectiveness of hypoglycemia, cold exposure and fasting in stimulating GH secretion in the mouse
49. Diurnal pattern of blood glucose, serum FFA, insulin, glucagon and growth hormone in normals and juvenile diabetics
50. Augmented growth hormone secretory burst frequency and amplitude mediated enhanced GH secretion during a two-day fast in normal men
51. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn
52. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children
53. Leprechaunism: Studies of the relationship among hyperinsulinism, insulin resistance, and growth retardation
54. Islet amyloidosis in a patient with chronic massive insulin resistance due to antiinsulin receptor antibodies